NanOptima
Alderley Edge
About NanOptima
NanOptima seeks to significantly enhance the existing standard of care for retinal illnesses by maintaining constant intraocular medication concentrations, as opposed to traditional injections.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Seed (Mar 2021)
- Website: nanoptima.com
- Phone: 07887 727 999
Industries & Categories
Biotechnology, Product Research
Social Profiles
Canonical: https://fsome.com/organization/nanoptima-3076673 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.